Next Article in Journal
A Case of Pleomorphic Dermal Sarcoma: Giant Exophytic Tumor of the Medial Canthus
Previous Article in Journal
Claudin-4 Upregulation in Acantholytic and Autoimmune-Mediated Bullous Disorders
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Perforating Fibrous Histiocytoma Mimicking Keratoacanthoma: A Case Report

1
Department of Clinical Pathology, Geneva University Hospitals (HUG), 1205 Geneva, Switzerland
2
Department of Dermatology and Venereology, Geneva University Hospitals (HUG), 1205 Geneva, Switzerland
*
Author to whom correspondence should be addressed.
Dermatopathology 2024, 11(1), 8-12; https://doi.org/10.3390/dermatopathology11010002
Submission received: 18 October 2023 / Revised: 24 November 2023 / Accepted: 21 December 2023 / Published: 25 December 2023
(This article belongs to the Section Clinico-Pathological Correlation in Dermatopathology)

Abstract

:
A 31-year-old male presented with a firm, well-demarcated, erythematous, crateriform, and ulcerated nodule in the left lumbar region, which persisted for 3 months. Clinically, a keratoacanthoma was suspected. The histological analysis was consistent with perforating fibrous histiocytoma, a rare histopathologic variant of fibrous histiocytoma. To our knowledge, this is the third case reported in the literature.

1. Introduction

Fibrous histiocytoma (FH) or dermatofibroma is a common benign skin lesion, accounting for approximately 3% of skin lesion samples received by dermatopathology laboratories [1]. It usually occurs between the second and forth decades, mostly in females [2] as a slow-growing solitary small plaque or nodule, or sometimes as multiple lesions, and it is associated with a low recurrence rate (2–5%) [3].
Histologically, FH is characterized by a sparsely or highly cellular dermal proliferation of fibrohistiocytic, usually spindle cells, organized in fascicles or in a storiform pattern in a fibrous stroma with a characteristic “entrapment” of collagen fibers at the periphery of the lesion. Follicular or sebaceous induction may be observed in the overlying epidermis, which is usually hyperplastic and hyperpigmented. Depending on the histological variant, the cellularity can vary, and the cells might also be epithelioid, lipidized, atypical, multinucleated, and hemosiderotic deposits, or pseudovascular hemorragic spaces could be observed. Different variants can coexist in the same lesion [4].
In one of the largest retrospective cohort studies published in 2014, which included 192 cases, FH was reported to be most often localized on the limbs (74% of cases). Numerous histopathological variants have been described, the most frequent of which are the following: common FH (80%), aneurysmal (5.7%), hemosiderotic (5.7%), epithelioid (2.6%), cellular (2.1%), lipidized (2.1%), atrophic (1.0 %), and clear cell (0.5%) variants. In this study, no perforating FH was reported [5]. Since they have different probabilities of local recurrence and, in some rare controversial cases, metastasis, the clinical presentation as well as the correct identification of histopathological features of different variants of FH are essential in making the correct diagnosis and in determining the prognosis [5,6]. Multiple FHs, and/or eruptive FH, have been observed in the context of immunosuppression, HIV infection, with highly active antiretroviral therapy (HAART), during pregnancy, in systemic lupus erythematous, and in some acquired perforating dermatosis (APD) as Kyrle’s disease, perforating folliculitis, reactive perforating collagenosis, and elastosis perforans serpiginosa [5,7,8].
The origin of FH remains unclear; nevertheless, there is an increasing number of studies pointing toward a neoplastic origin. Some cases of FH have been found to carry gene fusions involving protein kinase C isoenzymes PRKCA, PRKCB, and PRKCD and occasionally involving the ALK gene [9,10]. An overexpression of FGFR1 (fibroblast growth factor receptor 1), FGFR2, and FGFR4 was also described in some subtypes of FH. Overexpression of FGFRs leads to the activation of MAPK and PI3K/Akt pathways, which is a well-known growth-stimulatory mechanism encountered in benign and malignant tumors [9].

2. Case Report

We report the case of a 31-year-old male without any past medical history who presented with a 3-month-standing ulcerated nodule on his lower back, without associated pruritus or history of trauma.
Clinical examination revealed a firm, well-demarcated, erythematous, crateriform, and focally ulcerated nodule measuring approximatively 1 cm (Figure 1). The clinical differential diagnosis included keratoacanthoma, basal cell carcinoma, and amelanotic malignant melanoma.
The histological analysis of the surgical excisional specimen revealed a relatively well-demarcated fusocellular proliferation in the superficial and deep dermis. The lesion was composed of bundles of bland spindle cells arranged in a haphazard to focally storiform pattern (Figure 2a). The spindle cells showed abundant eosinophilic cytoplasm and an oval nucleus with vesicular chromatin without significant cytonuclear atypia. In the periphery, there were entrapped, thickened, globular collagen fibers. The overlying epidermis showed a pseudoepitheliomatous hyperplasia and in the center of the lesion, an ulceration topped with a crust, with some fascicles of spindle cells, collagen, and elastic fibers “perforating” the crust in a perpendicular fashion (Figure 2b,c). There were also rare cells that seemed to perforate the epidermis. The tumor cells were partially positive for Factor XIII (Figure 2d), scanty for CD68, and negative for CD34 and keratins. These histologic features were consistent with perforating FH. The negativity of CD34 ruled out differential diagnoses characterized by a CD34-positive fibrohistiocytic proliferation, including dermatofibrosarcoma protuberans. Moreover, the proliferation index evaluated with Mib-1 (Ki-67) within the lesion was very low (<1%).

3. Discussion

We report here a unique case of perforating FH. To our knowledge, only two previous cases have been reported in the literature [11,12]. The first one involved the lower limb of a 12-year-old boy [11], while the second one involved the posterior side of the left auricle of an 82-year-old woman [12].
In the first case, the lesion presented clinically as a 6 mm, firm, nontender, dusky-red to greyish dermal nodule on his left popliteal fossa. It showed a central carteriform aspect, with the exteriorization of dermal components. Histologically, the lesion was located in the upper dermis; it was mostly formed out of epithelioid cells associating with scattered multinucleated giant cells, such as Touton, foreign body, and osteoclast-like types. The lower part contained mainly spindle cells in a storiform pattern with collagen trapping. In the perforating part, macrophages and vertically oriented collagen bundles were described. The presumed explanation for the mechanism precipitating the accumulation of giant cells in FH proposed in this paper was hypoxia and reparative changes in the setting of local irritation [11].
In the second case, the lesion presented clinically as an 8 mm hyperkeratotic erythematous papular lesion on the posterior side of the left auricle with a clinical differential diagnosis including a keratoacanthoma and a squamous cell carcinoma. The excisional biopsy showed a dermal proliferation of fibrohistiocytic cells with a hyperplastic and invaginated epidermis containing keratin and cellular debris, and at the dermal-epidermal junction, it showed fibrin deposits and a sub-epidermal cleavage, suggesting FH accompanied by a perforating dermatosis. No recurrence was detected during her follow-up [12].
We noticed that there were striking clinical similarities between the three cases, leading us to suggest that perforating FH could be regarded as a distinct clinical-pathological entity. This variant should be considered in the differential diagnosis of a crateriform nodule. Table 1 summarizes the main clinical and histological characteristics of each case.
Common clinical differential diagnoses to consider facing a centrally ulcerated, keratotic, plugged, and umbilicated papule or nodule include keratoacanthoma, squamous cell carcinoma, molluscum contagiosum, prurigo nodularis, common wart, etc., but, usually, these entities are easy to distinguish histologically. Nevertheless, some other rare perforating conditions including inflammatory, tumoral, or deposition diseases may present as a single papular, nodular, ombilicated, or crateriform lesion: perforating granuloma annulare [13], involuted Spitz naevus with transepidermal elimination [14], perforating pilomatricoma [15], perforating metastasis from an ovarian adenocarcinoma [16,17], amyloïdosis, calcinosis cutis, osteoma cutis [18], the verrucous variant of perforating collagenoma or ARPC [19], and perforating gout [20].
Several mechanisms are thought to lead to perforation. Trauma from scratching was suggested to be a major trigger of perforating disorders, inducing damage to the epidermis or dermal collagen, resulting in the transepidermal elimination of collagen or elastic fibers. The alteration in collagen or elastic fibers due to metabolic disturbances or microdeposition of various substances represents another hypothesis [7]. Some authors also support the hypothesis that ischemic epidermal alterations may result in the destruction of the epidermis [21].

4. Conclusions

Although this is only the third reported case, the striking clinical similarity of the three cases leads us to believe that perforating FH could be a genuine clinical-pathological entity. Perforating FH represents a very rare histologic variant of FH that can present clinically as a crateriform nodule mimicking keratoacanthoma. These are the reasons why we would like to raise awareness of this entity among pathologists, dermatopathologists, and dermatologists. This entity may be possibly under-reported, and further studies are needed to determine whether it also has particular biological and/or molecular characteristics.

Author Contributions

Conceptualization, A.L. and S.M.; investigation, A.L., S.M. and A.H.; writing—original draft preparation, A.L.; writing—review and editing, A.L., S.M. and G.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed and written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to patient privacy.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Han, T.Y.; Chang, H.S.; Lee, J.H.; Lee, W.M.; Son, S.J. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann. Dermatol. 2011, 23, 185–192. [Google Scholar] [CrossRef] [PubMed]
  2. Aloi, D.F.; Albertazzi, M.P. Dermatofibroma with Granular Cells: A Report of Two Cases. Dermatology 1999, 199, 54–56. [Google Scholar] [CrossRef] [PubMed]
  3. Lee, J. Epithelioid Cell Histiocytoma with Granular Cells. (Another Nonneural Granular Cell Neoplasm). Am. J. Dermatopathol. 2007, 29, 475–476. [Google Scholar] [CrossRef] [PubMed]
  4. del Carmen Gómez-Mateo, M.; Monteagudo, C. Nonepithelial skin tumors with multinucleated giant cells. Semin. Diagn. Pathol. 2013, 30, 58–72. [Google Scholar] [CrossRef] [PubMed]
  5. Alves, J.V.P.; Matos, D.M.; Barreiros, H.F.; Bártolo, E.A.F.L.F. Variants of dermatofibroma—A histopathological study. An. Bras. Dermatol. 2014, 89, 472–477. [Google Scholar] [CrossRef] [PubMed]
  6. Luzar, B.; Calonje, E. Cutaneous fibrohistiocytic tumours—An update. Histopathology 2010, 56, 148–165. [Google Scholar] [CrossRef] [PubMed]
  7. Kim, S.W.; Kim, M.S.; Lee, J.H.; Son, S.J.; Park, K.Y.; Li, K.; Seo, S.J.; Han, T.Y. A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea. Ann. Dermatol. 2014, 26, 162–171. [Google Scholar] [CrossRef] [PubMed]
  8. Zaccaria, E.; Rebora, A.; Rongioletti, F. Multiple eruptive dermatofibromas and im-munossupression: Report of two cases and review of the literature. Int. J. Dermatol. 2008, 47, 723–727. [Google Scholar] [CrossRef]
  9. Płaszczyca, A.; Nilsson, J.; Magnusson, L.; Brosjö, O.; Larsson, O.; von Steyern, F.V.; Domanski, H.; Lilljebjörn, H.; Fioretos, T.; Tayebwa, J.; et al. Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma. Int. J. Biochem. Cell Biol. 2014, 53, 475–481. [Google Scholar] [CrossRef]
  10. Walther, C.; Hofvander, J.; Nilsson, J.; Magnusson, L.; Domanski, H.A.; Gisselsson, D.; Tayebwa, J.; Doyle, L.A.; Fletcher, C.D.M.; Mertens, F. Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing. Lab. Investig. 2015, 95, 1071–1076. [Google Scholar] [CrossRef]
  11. Kim, E.J.; Park, H.S.; Yoon, H.S.; Cho, S. A case of perforating dermatofibroma with floret-like giant cells. Clin. Exp. Dermatol. 2014, 40, 305–308. [Google Scholar] [CrossRef] [PubMed]
  12. Aydin, E.; Vardareli, O.S.; Bilezikçi, B.; Ozgirgin, O.N. Dermatofibroma accompanied by perforating dermatosis in the auricle: A case report. Kulak Burun Bogaz Ihtis Derg. 2005, 15, 83–86. [Google Scholar] [PubMed]
  13. Samlaska, S.P.; Sandberg, G.D.; Maggio, K.L.; Sakas, E.L. Generalized perforating granuloma annulare. J. Am. Acad. Dermatol. 1992, 27, 319–322. [Google Scholar] [CrossRef] [PubMed]
  14. Kobayashi, H.; Oishi, K.; Miyake, M.; Nishijima, C.; Kawashima, A.; Kobayashi, H.; Inaoki, M. Spitz nevus on the sole of the foot presenting with transepidermal elimination. Dermatol. Pract. Concept. 2014, 4, 41–43. [Google Scholar] [CrossRef] [PubMed]
  15. Kang, H.Y.; Kang, W.H. Guess what! Perforating pilomatricoma resembling keratoacanthoma. Eur. J. Dermatol. 2000, 10, 63–64. [Google Scholar] [PubMed]
  16. Abbas, O.; Salem, Z.; Haddad, F.; Kibbi, A.-G. Perforating cutaneous metastasis from an ovarian adenocarcinoma. J. Cutan. Pathol. 2010, 37, 53–56. [Google Scholar] [CrossRef]
  17. Morton, C.A.; Henderson, I.S.; Jones, M.C.; Lowe, J.G. Acquired perforating dermatosis in a British dialysis population. Br. J. Dermatol. 1996, 135, 671–677. [Google Scholar] [CrossRef]
  18. Patterson, J.W. The perforating disorders. J. Am. Acad. Dermatol. 1984, 10, 561. [Google Scholar] [CrossRef]
  19. Pigariolo, C.B.; Maronese, C.A.; Giacalone, S.; Gianotti, R.; Marzano, A.V.; Veraldi, S. Persistent variant of acquired verrucous perforating collagenoma. Int. J. Dermatol. 2022, 61, 333–335. [Google Scholar]
  20. Bohdanowicz, M.; Bradshaw, S.H. Perforating Gout: Expanding the Differential for Transepidermal Elimination. Dermatopathology 2023, 10, 207–218. [Google Scholar] [CrossRef]
  21. Penas, P.F.; Jones-Caballero, M.; Fraga, J.; Sánchez-Pérez, J.; García-Díez, A. Perforating granuloma annulare. Int. J. Dermatol. 1997, 36, 340–348. [Google Scholar] [CrossRef]
Figure 1. A well-demarcated, erythematous, crateriform nodule with central ulceration.
Figure 1. A well-demarcated, erythematous, crateriform nodule with central ulceration.
Dermatopathology 11 00002 g001
Figure 2. Histopathology of perforating fibrous histiocytoma: relatively well-demarcated cellular infiltrate of spindle cells in the superficial and deep dermis ((a) hematoxylin-eosin stain, ×10) with an overlying superficial ulceration, with spindle cells surrounding collagen bundle (pointed out by arrows) that “perforates” the crust ((b), hematoxylin-eosin stain, ×30), along with collagen (pointed out by arrows) and elastic fibers (pointed out by asterisks) ((c), Miller’s stain, ×30). Factor XIII partial positivity ((d), Factor XIII immunostain, ×10).
Figure 2. Histopathology of perforating fibrous histiocytoma: relatively well-demarcated cellular infiltrate of spindle cells in the superficial and deep dermis ((a) hematoxylin-eosin stain, ×10) with an overlying superficial ulceration, with spindle cells surrounding collagen bundle (pointed out by arrows) that “perforates” the crust ((b), hematoxylin-eosin stain, ×30), along with collagen (pointed out by arrows) and elastic fibers (pointed out by asterisks) ((c), Miller’s stain, ×30). Factor XIII partial positivity ((d), Factor XIII immunostain, ×10).
Dermatopathology 11 00002 g002
Table 1. Comparative table with clinical and pathological characteristics of each described case of perforating FH.
Table 1. Comparative table with clinical and pathological characteristics of each described case of perforating FH.
FeaturesCharacteristicsCase 1Case 2Our Case
ClinicalGenderMaleFemaleMale
Age (years)128231
SiteBack of the kneeLeft auricleLower back
Diameter (mm) of the lesion6810
Histopathological Epidermal perforationPresentPresentPresent
Extruded materialGiant cells
Macrophages
Collagen bundles
Collagen bundlesCollagen bundles
Elastic fibers
Spindle cells
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lungu, A.; Hsieh, A.; Kaya, G.; Menzinger, S. Perforating Fibrous Histiocytoma Mimicking Keratoacanthoma: A Case Report. Dermatopathology 2024, 11, 8-12. https://doi.org/10.3390/dermatopathology11010002

AMA Style

Lungu A, Hsieh A, Kaya G, Menzinger S. Perforating Fibrous Histiocytoma Mimicking Keratoacanthoma: A Case Report. Dermatopathology. 2024; 11(1):8-12. https://doi.org/10.3390/dermatopathology11010002

Chicago/Turabian Style

Lungu, Alina, Aurélie Hsieh, Gürkan Kaya, and Sébastien Menzinger. 2024. "Perforating Fibrous Histiocytoma Mimicking Keratoacanthoma: A Case Report" Dermatopathology 11, no. 1: 8-12. https://doi.org/10.3390/dermatopathology11010002

APA Style

Lungu, A., Hsieh, A., Kaya, G., & Menzinger, S. (2024). Perforating Fibrous Histiocytoma Mimicking Keratoacanthoma: A Case Report. Dermatopathology, 11(1), 8-12. https://doi.org/10.3390/dermatopathology11010002

Article Metrics

Back to TopTop